Cargando…

Efficacy of inhaled tobramycin in severe nosocomial pneumonia

Detalles Bibliográficos
Autores principales:	Kuzovlev, A, Polovnikov, S, Stec, V, Varvarin, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363489/ http://dx.doi.org/10.1186/cc10678

Ejemplares similares

Inhaled tobramycin for the treatment of nosocomial pneumonia in sepsis
por: Kuzovlev, A, et al.
Publicado: (2014)

Complex approach for diagnosing acute respiratory distress syndrome in nosocomial pneumonia
por: Kuzovlev, A, et al.
Publicado: (2015)

Early preventive administration of inhaled tobramycin in severe polytrauma
por: Kuzovlev, A, et al.
Publicado: (2015)

Club Cell protein: a candidate diagnostic biomarker of Pseudomonas aeruginosa nosocomial pneumonia
por: Moroz, V, et al.
Publicado: (2014)

On the diagnosis of acute respiratory distress syndrome in nosocomial pneumonias
por: Kuzovlev, A, et al.
Publicado: (2010)

Biomarkers for early stage of acute respiratory distress syndrome in septic patients: surfactant protein D and Clara cell protein
por: Kuzovlev, A, et al.
Publicado: (2013)

Bacteremic nosocomial pneumonia cases from the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2010)

Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation
por: Gauthier, Timothy P., et al.
Publicado: (2015)

Nosocomial pneumonia in the postoperative period after heart transplantation
por: Gómez López, R, et al.
Publicado: (2013)

Nosocomial pneumonia in ICU patients after surgical and percutaneous tracheostomy
por: Tsirantonaki, M, et al.
Publicado: (2006)

Nosocomial pneumonia and the main victim: the older person – measures for ventilator-associated pneumonia control
por: Guimarães, MMQ, et al.
Publicado: (2009)

Nosocomial pneumonia: impact of a very early antimicrobial therapy
por: Montesino, L, et al.
Publicado: (2005)

Severe sepsis and sepsis shock secondary to non ventilator associated nosocomial pneumonia. principal features and predictors of outcome
por: Zaragoza, R, et al.
Publicado: (2015)

Piperacillin/tazobactam administered by continuous or intermittent infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2009)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

Protective effect of antibiotic prophylaxis against early-onset nosocomial pneumonia in comatose patients
por: Navellou, J, et al.
Publicado: (2007)

Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia
por: Nassar, YS, et al.
Publicado: (2015)

Surfactant protein A: a candidate predictive biomarker of mortality in acute respiratory distress syndrome in sepsis
por: Moroz, V, et al.
Publicado: (2014)

Serum tobramycin levels during selective decontamination of the digestive tract in ICU patients on renal replacement therapy
por: Mol, M, et al.
Publicado: (2008)

Comparing a Brazilian guideline to treat nosocomial pneumonia with the ATS guideline in a tertiary hospital in Brazil
por: Kalichsztein, M, et al.
Publicado: (2007)

Adherence with tobramycin inhaled solution and health care utilization
por: Briesacher, Becky A, et al.
Publicado: (2011)

Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
por: Vendrell, Montserrat, et al.
Publicado: (2015)

Recurrence of Gram-negative nosocomial pneumonia in the critically ill patient following short-course antibiotic therapy
por: Pugh, Richard, et al.
Publicado: (2007)

Oral chlorhexidine to prevent nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis
por: Pugh, RJ, et al.
Publicado: (2010)

Predictive and prognostic factors of septic shock of nosocomial origin
por: Quenot, JP, et al.
Publicado: (2012)

P038: Efficacy of prevention measures against nosocomial influenza at a large university hospital
por: Iten, A, et al.
Publicado: (2013)

Effects of reintubation on ventilator associated nosocomial pneumonias incidence in ICU patients with versus without selective digestive decontamination
por: Marrero-Rodríguez, AM, et al.
Publicado: (2015)

Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator‐associated pneumonia: An open‐label randomized controlled trial
por: Hakamifard, Atousa, et al.
Publicado: (2023)

Epidemiology and etiology of nosocomial infections in a surgical intensive care unit
por: Gelfand, B, et al.
Publicado: (2005)

Uteroglobin-related protein 1 and severity of inhalation injury
por: Friedman, G, et al.
Publicado: (2015)

Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
por: Ting, L, et al.
Publicado: (2014)

Gram-positive nosocomial infections in a general ICU: emerging new clues
por: Milanov, S, et al.
Publicado: (2011)

Gram-positive nosocomial infections in a general ICU: searching for a clue
por: Georgiev, G, et al.
Publicado: (2008)

Surveillance for nosocomial pathogens in our ICU
por: Kawano, Y, et al.
Publicado: (2014)

Nosocomial infection in patients with brain trauma
por: Lorente, L, et al.
Publicado: (2006)

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii
por: Alarfaj, Reem E., et al.
Publicado: (2022)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Effect of continuous high-volume hemofiltration on patients with acute respiratory distress syndrome
por: Kuzovlev, A, et al.
Publicado: (2013)

Analysis of nosocomial bacteremia in an ICU during 16 months
por: Cachafeiro, L, et al.
Publicado: (2011)

The microbiological profile of nosocomial infections in an intensive care unit
por: Madhurima, P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s8klvno3gkiic0cgvhnggvimc5